Pallavi G, Gupta K L Virupaksha, Shreevathsa M, Chate Vasudev A, Balakrishna D L
Department of Basic Principles, Gaur Brahman Ayurvedic College, Rohtak, Haryana, India.
Department of Rasa Shastra and Bhaishajya Kalpana, Gaur Brahman Ayurvedic College, Rohtak, Haryana, India.
Ayu. 2015 Apr-Jun;36(2):151-6. doi: 10.4103/0974-8520.175543.
Vyanga type of Kshudra Roga, characterised by Niruja (painless), Shyava Varna Mandalas (bluish black patches) occurring especially on the face. The clinical features correlate with melasma, which is an acquired chronic hyperpigmentation disorder, usually seen in women of childbearing age. The drugs which constitute the Varnya Gana Lepa bestow the normal Varna (color) by virtue of their qualities and actions.
To determine the efficacy of Varnya Gana Lepa in the management of Vyanga.
The study was a single armed clinical trial in which total 40 patients of Vyanga belonging to the age group of 16-60 years were enrolled. Paste for external application was prepared by mixing the fine powders of 10 drugs (in equal quantity) of Varnya Gana with lukewarm water and advised to apply Lepa twice daily for 15 days on affected part. The different parameters such as skin color, lesion color, texture-dryness/oiliness, luster, number and size of the lesions, darkness, area and homogeneity of lesion, itching, burning sensation, and melasma area severity index (MASI) score were assessed.
There was statistically significant improvement in MASI scores, but in overall assessment, 64.5% patients had mild improvement. Clinical improvement was more evident in darkness parameter when compared to other parameters.
The study concludes that Varnya Gana Lepa is a safe and effective formulation in the management of Vyanga (melasma).
微扬卡型的庶病,其特征为无痛,尤其在面部出现蓝黑色斑块。临床特征与黄褐斑相关,黄褐斑是一种后天性慢性色素沉着障碍,常见于育龄女性。组成色泽类药膏的药物凭借其特性和作用赋予正常肤色。
确定色泽类药膏治疗微扬卡病的疗效。
该研究为单臂临床试验,共纳入40例年龄在16至60岁之间的微扬卡病患者。将色泽类的10种药物(等量)的细粉与温水混合制备外用膏剂,并建议每天在患处涂抹药膏两次,持续15天。评估了不同参数,如肤色、皮损颜色、质地(干性/油性)、光泽、皮损数量和大小、暗沉度、皮损面积和均匀度、瘙痒、烧灼感以及黄褐斑面积严重程度指数(MASI)评分。
MASI评分有统计学意义的改善,但总体评估中,64.5%的患者有轻度改善。与其他参数相比,暗沉参数的临床改善更为明显。
该研究得出结论,色泽类药膏是治疗微扬卡病(黄褐斑)的一种安全有效的制剂。